The Unfulfilled Promises of Genome Sequencing and the Future of Disease Detection

Helmy Eltoukhy, chairman of Guardant Health, reflects on the unfulfilled promises of genome sequencing and the challenges in disease detection. Despite the advancements, common illnesses still persist. He emphasizes the significance of the epigenome in disease detection and the potential for early diagnosis. Eltoukhy cautions the healthcare industry about the need to prioritize utility over information, innovate business models, and start small to address unmet needs. He foresees an exciting decade for healthcare entrepreneurs and physicians, envisioning a future where diseases can be detected before birth.